Laparoscopic Roux-en-Y gastric bypass and its early effect on blood pressure

Obes Surg. 2009 Jul;19(7):845-9. doi: 10.1007/s11695-008-9671-z. Epub 2008 Aug 30.

Abstract

Background: Laparoscopic Roux-en-Y gastric bypass (LRYGB) surgery is known to have a significant effect on obesity-related comorbidities such as hypertension curing it in some (50-70%) while improving control in others. Our aim was to observe the changes in blood pressure (BP) in a cohort of 100 patients followed prospectively for 1 year after LRYGB.

Methods: BP measurements were recorded prospectively in 100 consecutive patients preoperatively and then postoperatively at weeks 1, 5, 9, and months 6 and 12. In order to reduce bias, three BP measurements were made by the same nurse at each office visit and the mean recorded. Pre- and postoperative usage of antihypertensive medication was also noted.

Results: Eighty-nine women and 11 men underwent LRYGB and their BP monitored for 1 year. There was an 85% follow-up rate with mean % excess body weight loss of 60. Reductions in systolic (9 mmHg) and diastolic (7 mmHg) BP measurements were seen as early as week 1 postoperatively and maintained for the duration of the observation period (P < 0.05). Furthermore, postoperative usage of antihypertensive medication is reduced to a third of preoperative use.

Conclusion: LRYGB is associated with an early reduction in BP and antihypertensive medication usage which is maintained at 1 year after surgery. This early impact on blood pressure occurs before any significant weight loss is achieved thereby suggesting a hormonal mechanism that may be involved for the changes observed.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure / physiology*
  • Cohort Studies
  • Female
  • Gastric Bypass*
  • Humans
  • Hypertension / drug therapy
  • Hypertension / surgery*
  • Laparoscopy / methods*
  • Male
  • Middle Aged
  • Obesity, Morbid / physiopathology
  • Obesity, Morbid / surgery*
  • Prospective Studies
  • Weight Loss
  • Young Adult

Substances

  • Antihypertensive Agents